- Home
- SNGX vs AMZE Comparison
SNGX vs AMZE Comparison
Compare SNGX & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- AMZE
- Stock Information
- Founded
- SNGX 1987
- AMZE 2019
- Country
- SNGX United States
- AMZE United States
- Employees
- SNGX N/A
- AMZE N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- SNGX Health Care
- AMZE Consumer Staples
- Exchange
- SNGX Nasdaq
- AMZE Nasdaq
- Market Cap
- SNGX 13.8M
- AMZE 12.3M
- IPO Year
- SNGX 1987
- AMZE 2021
- Fundamental
- Price
- SNGX $1.48
- AMZE $0.30
- Analyst Decision
- SNGX Strong Buy
- AMZE
- Analyst Count
- SNGX 1
- AMZE 0
- Target Price
- SNGX $6.00
- AMZE N/A
- AVG Volume (30 Days)
- SNGX 256.3K
- AMZE 31.8M
- Earning Date
- SNGX 11-07-2025
- AMZE 11-14-2025
- Dividend Yield
- SNGX N/A
- AMZE N/A
- EPS Growth
- SNGX N/A
- AMZE N/A
- EPS
- SNGX N/A
- AMZE N/A
- Revenue
- SNGX N/A
- AMZE $2,245,143.00
- Revenue This Year
- SNGX N/A
- AMZE $6,741.66
- Revenue Next Year
- SNGX N/A
- AMZE $100.61
- P/E Ratio
- SNGX N/A
- AMZE N/A
- Revenue Growth
- SNGX N/A
- AMZE 369.95
- 52 Week Low
- SNGX $1.09
- AMZE $0.24
- 52 Week High
- SNGX $6.23
- AMZE $19.44
- Technical
- Relative Strength Index (RSI)
- SNGX 47.15
- AMZE 25.20
- Support Level
- SNGX $1.25
- AMZE $0.24
- Resistance Level
- SNGX $1.47
- AMZE $0.64
- Average True Range (ATR)
- SNGX 0.11
- AMZE 0.11
- MACD
- SNGX 0.02
- AMZE 0.04
- Stochastic Oscillator
- SNGX 65.45
- AMZE 9.19
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.